IL6 and neoplasm: DTP cells also actively reshape the tumor microenvironment (TME) by secreting IL-6, TGF-β, and CXCL12, which recruit immunosuppressive cells (e.g., TAMs, Tregs), thereby reinforcing drug tolerance and promoting tumor recurrence (Oren et al., 2021).